Valeria Fantin is the Global Head of Oncology Research at Sanofi. Valeria joined Sanofi in 2021 and has more than 16 years of industry experience in exploratory biology and oncology drug discovery and development.
Valeria is a passionate scientist who has been at the forefront of discovery research in oncology and has an impressive track record collaborating with teams and managing external collaborations.
Prior to her role at Sanofi, she led Oncology Research at Gilead Sciences, with a focus on immuno-oncology as well as mechanisms of tumorigenesis and therapy resistance.
Valeria earned her B.S. in Chemistry from Universidad del Salvador-Argentina and her Ph.D. in Molecular and Cellular Biology from Dartmouth Medical School. She completed her postdoctoral training in cancer metabolism and signal transduction at Harvard Medical School and the Howard Hughes Medical Institute.
We now see the next wave of potential cancer therapies on the horizon, propelled by significant advancements in immunology, as well as an increased understanding of tumor-driven mechanisms of immune evasion.